Literature DB >> 33044245

Hypogonadism and metabolic syndrome: review and update.

William T Berg1, Martin Miner2.   

Abstract

PURPOSE OF REVIEW: The prevalence of metabolic syndrome and hypogonadism continues to rise in the United States and around the world. These two conditions are inexorably linked, and understanding their relationship with each other is key to treating men with either of these conditions. RECENT
FINDINGS: Testosterone has been shown to be a key regulator in the maintenance of metabolic homeostasis. A large volume of research has found that testosterone deficiency is closely linked to metabolic syndrome through complex physiologic mechanisms of endothelial dysfunction, inflammation, and glucose metabolism.
SUMMARY: Interventions through lifestyle modification and testosterone replacement in hypogonadal men may reduce the morbidity and mortality risks associated with metabolic syndrome.

Entities:  

Year:  2020        PMID: 33044245     DOI: 10.1097/MED.0000000000000582

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  3 in total

1.  Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles.

Authors:  Natalia Leciejewska; Paweł A Kołodziejski; Maciej Sassek; Leszek Nogowski; Emilian Małek; Ewa Pruszyńska-Oszmałek
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 2.  Metabolic Syndrome and Male Fertility: Beyond Heart Consequences of a Complex Cardiometabolic Endocrinopathy.

Authors:  Gianmaria Salvio; Alessandro Ciarloni; Melissa Cutini; Nicola Delli Muti; Federica Finocchi; Michele Perrone; Silvia Rossi; Giancarlo Balercia
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

3.  Health burden in type 2 diabetes and prediabetes in The Maastricht Study.

Authors:  Marja G J Veugen; Veronica G Onete; Ronald M A Henry; Hans-Peter Brunner-La Rocca; Annemarie Koster; Pieter C Dagnelie; Nicolaas C Schaper; Simone J S Sep; Carla J H van der Kallen; Martin P J van Boxtel; Koen D Reesink; Johannes S Schouten; Hans H C M Savelberg; Sebastian Köhler; Frans R Verhey; Joop P W van den Bergh; Miranda T Schram; Coen D A Stehouwer
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.